Glenmark Pharmaceuticals standalone net profit rises 222.52% in the June 2015 quarter

Sales rise 106.65% to Rs 1225.90 crore

Net profit of Glenmark Pharmaceuticals rose 222.52% to Rs 335.20 crore in the quarter ended June 2015 as against Rs 103.93 crore during the previous quarter ended June 2014. Sales rose 106.65% to Rs 1225.90 crore in the quarter ended June 2015 as against Rs 593.22 crore during the previous quarter ended June 2014. ParticularsQuarter EndedJun. 2015Jun. 2014% Var.Sales1225.90593.22 107 OPM %34.8820.59 -PBDT445.41130.35 242 PBT418.79121.75 244 NP335.20103.93 223

Powered by Capital Market - Live News